BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dev California Life Sciences - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://dev.califesciences.org
X-WR-CALDESC:Events for Dev California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230919
DTEND;VALUE=DATE:20230920
DTSTAMP:20260407T064933
CREATED:20220225T015007Z
LAST-MODIFIED:20230518T151004Z
UID:6671-1695081600-1695081600@dev.califesciences.org
SUMMARY:Science of Stability (SOS) Conference
DESCRIPTION:Location: Philadelphia\, PA \n  \nThe Science of Stability (SOS) Conference exposes attendees to the latest discoveries and innovations in the science of stability across different industries that include pharmaceuticals\, generics\, nutraceuticals\, Over-the-Counter (OTC)\, and consumer products. It is a must-attend program for anyone interested in accelerated aging\, degradation chemistry\, and stability. SOS 2022 will be the 7th Science of Stability Conference\, proudly sponsored by FreeThink Technologies\, Inc. \nRegister»
URL:https://dev.califesciences.org/event/science-of-stability-sos-conference/
LOCATION:Science History Institute\, 315 Chestnut Street\, Philadelphia\, PA\, 19106\, United States
CATEGORIES:Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220811T090000
DTEND;TZID=America/New_York:20220811T130000
DTSTAMP:20260407T064933
CREATED:20220414T195142Z
LAST-MODIFIED:20220420T164018Z
UID:7834-1660208400-1660222800@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 4  Actualizing Change
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities-pt-4-actualizing-change/
LOCATION:Live\, Online
CATEGORIES:Member Events,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220616T090000
DTEND;TZID=America/New_York:20220616T130000
DTSTAMP:20260407T064933
CREATED:20220414T194811Z
LAST-MODIFIED:20220414T195517Z
UID:7832-1655370000-1655384400@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 3 Reimagining Translational Science
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities-pt-3-reimagining-translational-science/
LOCATION:Virtual
CATEGORIES:Member Events,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220607T080000
DTEND;TZID=America/New_York:20220609T170000
DTSTAMP:20260407T064933
CREATED:20220505T214511Z
LAST-MODIFIED:20220602T171808Z
UID:8380-1654588800-1654794000@dev.califesciences.org
SUMMARY:Lonza Biologics Roadshow - Preparing for a Successful Transition to the Clinic
DESCRIPTION:Lonza Bench to Clinic avoid missing milestones\, rework or process failures for standard mAbs\, bispecifics\, bioconjugates\, and new molecular formats. Have a tailored conversation with our scientists and team about your candidates’ specific needs: \n\nDe-risking and optimizing your lead\nManufacturability screening\, protein engineering\, Humanization\, Assessing the potential immune response\nImmunogenicity\, Immunotoxicity and potency evaluation\, de-immunization Generating materials for your in vitro and preclinical studies • Non-GMP protein expression and supply\nGuaranteed antibody supply up to 2g within 6 weeks Creating cell lines and processes with future manufacturability\, cost of goods and speed in mind\nStandard monoclonal\, bispecific or new molecular formats – We have an approach for each\n11 months from DNA to IND. Guaranteed!*\nAccessing a global development and manufacturing network Lonza brings it together – One place\, your bioconjugate\, your solution\nNew Bioconjugates Early Development Service (EDS) offering\nTechnology Toolbox – Solution to find your way to IND\n\nContact alejandro.preciado@lonza.com to learn more! \nSet up a Tailored Discussion with our Experts:\nAlejandro Preciado\, Business Development Biologics\nJaime Okray\, Business Development Biologics\nYvette Stallwood\, Early De-risking and Lead Optimization Head Cambridge Site and Early Development Services\nNoel Smith\, Head Immunology\, Early Development Services Expression and Process Development\nJennifer Peuchot\, Group Leader Cell Culture Development\nMatthieu Settler\, Head of Mammalian Development Services\nSandro Holzer\, Head of Process Development\nRaphael Frey Senior Scientist Bioconjugates EDS\nChristoph Bernoulli\, Drug Product Development Head MSAT\nClaudia Müller Drug Product\, Head Formulation Development \n* For antibodies and antibody like molecules. From receipt of the gene sequence. Subject to terms and conditions.
URL:https://dev.califesciences.org/event/preparing-for-a-successful-transition-to-the-clinic/
LOCATION:CLS SSF Office\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220517T170000
DTEND;TZID=America/Los_Angeles:20220517T180000
DTSTAMP:20260407T064933
CREATED:20220427T180528Z
LAST-MODIFIED:20220427T180528Z
UID:8270-1652806800-1652810400@dev.califesciences.org
SUMMARY:2022 ACS CAN California Policy Roundtable and Awards Event
DESCRIPTION:The Registry is a comprehensive state-wide cancer surveillance program that collects information on cancers diagnosed in California and provides insight to develop strategies and policies for cancer prevention\, treatment\, and control to promote health equity among Californians living with cancer. \nWe will also honor State Senator Susan Rubio and Assemblymember Mike Gipson for championing legislation on behalf of cancer patients\, caregivers\, and their families. \nRegister»
URL:https://dev.califesciences.org/event/2022-acs-can-california-policy-roundtable-and-awards-event/
LOCATION:CA
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220406T101500
DTEND;TZID=America/Los_Angeles:20220406T120000
DTSTAMP:20260407T064933
CREATED:20220218T180755Z
LAST-MODIFIED:20220331T204532Z
UID:6483-1649240100-1649246400@dev.califesciences.org
SUMMARY:Johnson & Johnson Innovation - The Search for Solutions to the Delivery Challenges of Nucleic Acid-Based Therapies
DESCRIPTION:Location: Virtual \n  \nGene and nucleic acid therapies are increasingly being established as important modalities for the next generation of medicine. However\, in vivo delivery challenges currently limit their full potential to achieve more widespread clinical use. Scientific innovations are needed to improve the efficiency\, tissue biodistribution\, cellular/ tissue selectivity\, payload capacity\, and immunogenicity to enable therapies with enhanced safety and efficacy profiles. \nIn this webinar\, our panel of scientific experts and entrepreneurs will highlight some of the key delivery challenges facing the field of gene and nucleic acid therapeutics and will discuss select scientific innovations that are being undertaken with the aim to address these challenges. Discussion topics will include both viral and non-viral systems for delivery of DNA\, mRNA\, siRNA/ASO payloads in addition to cell/tissue specific targeting approaches. \nDPDS (Discovery\, Product Development and Supply) of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen)’s external innovation team invites innovators with potential solutions to these challenges to apply for an opportunity to meet 1-on-1 to discuss their innovative solutions. \nAreas of particular interest include unmet needs in:\n– Enhanced delivery to retina\, cochlea\, brain\, kidney\, and heart\n– Cell targeting moieties for selective cellular uptake\n– Lipid nanoparticles with cell targeting properties\n– AAV capsid engineering for improved biodistribution\n– Approaches to limit immune surveillance and response \nRegister»
URL:https://dev.califesciences.org/event/the-search-for-solutions-to-the-delivery-challenges-of-nucleic-acid-based-therapies/
LOCATION:Virtual
CATEGORIES:Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics11.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220325T080000
DTEND;TZID=America/Los_Angeles:20220325T090000
DTSTAMP:20260407T064933
CREATED:20220310T224234Z
LAST-MODIFIED:20220310T224337Z
UID:6894-1648195200-1648198800@dev.califesciences.org
SUMMARY:Halloran Town Hall: Total Data Control and Custody – Moving from Excel to Complete Integration for Better Clinical Trial Decisions
DESCRIPTION:We have certainly come a long way in clinical trial operations over the past few years as our industry collectively shifted to decentralized and hybrid models to collect patient data outside of the traditional site model. And sponsors have a lot of data. This growth\, though celebrated\, also comes with growing pains\, like figuring how to build a large data mapping infrastructure to harness the trial’s data for better insight and oversight. \nIf you’re experiencing a similar issue\, please join our Halloran-hosted virtual Town Hall on March 25\, 2022\, from 11:00a.m. – 12:00p.m. EST on “Total Data Control and Custody: Moving from Excel to Complete Integration for Better Clinical Trial Decisions” led by the global data strategy and innovation team at CSL Behring and joined by experts from Halloran. CSL Behring has recently designed a data infrastructure for their studies that allowed their teams to have better control over their data\, leading to more informed decisions. They have major lessons learned and context behind their change and will be sharing their insights with the panel (and you!) to work through the following: \nHow do you integrate data sources and automate processes to get to a point of total data control regardless of company size? \nHow to get executive buy-in around data standards and oversight? \nWhat does the planning entail? Where do we start? \nIs this the future of data? How should companies prepare? \nIf you too want to evolve in this direction\, there is significant time and money that will need to be spent well in advance of when the trial data needs to be submitted. So\, let’s brainstorm and learn from each other. We hope you can join us – and bring your questions – to talk through scenarios for better data strategy\, control\, and custody for better decision making. \nMeet the Panel: \nMeghan Powers\, Director\, Clinical Practice Operations\, Halloran Consulting Group; Karen Travers\, Associate Principal Consultant\, Organizational & Quality Solutions\, Halloran Consulting Group; Thomas Verish\, Head of Global Data Strategy & Innovation\, CSL Behring; Valerie Reynaert\, Head of Global Clinical Operations\, CSL Behring; Charles Johnson\, Director\, eClinical Operations\, CSL Behring; Tony Ciliberto\, Senior Director\, Global Clinical Operations\, CSL Behring \nRegister» \nUpon registration you will receive a calendar invite with Zoom info.
URL:https://dev.califesciences.org/event/halloran-town-hall-total-data-control-and-custody-moving-from-excel-to-complete-integration-for-better-clinical-trial-decisions/
LOCATION:Live\, Online
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
END:VCALENDAR